Complete Side Effect Breakdown Hair Loss: A Particular Concern for Women Although affecting only 3-4% of participants overall, hair thinning causes disproportionate distress for women
The new weight loss medications are approved by the Food and Drug Administration (FDA) only for obesity, which the agency defines as a body mass index of 30 or greater
Because retatrutide remains in clinical trials, its full side-effect profile has not been comprehensively established through post-marketing surveillance
Learn about Tonums research, trials, and evidence resources at Tonum Research to see how food, coaching and clinically tested supplements can complement your health plan
Supply: Reliably in stock through our pharmacy partner
This is suggestive of the effects of GLP-1-based therapies on attenuating inflammatory processes that may cause atherosclerosis development